In vivo germination of bacillus anthracis spores during murine cutaneous infection

Journal of Infectious Diseases

Volumn 207, Issue 3, 2013, Pages 450-457

  Corre, Jean Philippe ^a,b   Piris Gimenez, Alejandro ^a,b   Moya Nilges, Marie ^a,b   Jouvion, Gregory ^a   Fouet, Agnes ^a,b,c,d   Glomski, Ian J ^a,b,i   Mock, Michèle ^a,b   Sirard, Jean Claude ^a,b,e,f,g,h   Goossens, Pierre L ^a,b  

^a INSTITUT PASTEUR   (France)

^b CNRS   (France)

^c INSTITUT COCHIN   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e INSTITUT PASTEUR DE LILLE   (France)

^f UNIV LILLE   (France)

^g INSERM U1019   (France)

^h INSERM   (France)

ⁱ UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Bacillus anthracis; cutaneous infection; germination; mice; spore

Indexed keywords

AMPICILLIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTHRAX; ANTIBIOTIC SENSITIVITY; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL COUNT; BACTERIAL EXOSPORE; BACTERIAL GROWTH; BACTERIAL VIRULENCE; BLOOD SAMPLING; CELL CONTACT; CELL FREE SYSTEM; CELL INTERACTION; COLONY FORMING UNIT; CONTROLLED STUDY; FEMALE; GUINEA PIG; HOST PATHOGEN INTERACTION; IN VIVO STUDY; INOCULATION; LIVER; LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN ANTHRAX; SPLEEN; SPORE GERMINATION; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL CELL; BACTERIAL STRAIN; ELECTRON MICROSCOPY; LIVER CELL; LYMPH NODE CELL; MACROPHAGE; SKIN INFECTION; SPLEEN CELL;

ANIMALS; ANTHRAX; BACILLUS ANTHRACIS; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; FEMALE; GUINEA PIGS; HOST-PATHOGEN INTERACTIONS; LIVER; LYMPHOID TISSUE; MICE; SKIN DISEASES, BACTERIAL; SPLEEN; SPORES, BACTERIAL;

EID: 84872022925     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis686     Document Type: Article

References (49)

1. Friedlander AM. Chapter 22: Anthrax. In: Zajtchuk R, ed. Medical Aspects of Chemical and Biological Warfare. Washington, DC: Office of The Surgeon General, Borden Institute, Walter Reed Army Medical Center, 1997:467-78.
2. Mock M, Fouet A. Anthrax. Annu Rev Microbiol 2001; 55:647-71.
3. Spencer RC. Bacillus anthracis. J Clin Pathol 2003; 56:182-7.
4. Cromartie WJ, Bloom WL, Watson DW. Studies on infection with Bacillus anthracis. I. A histopathological study of skin lesions produced by B. anthracis in susceptible and resistant animal species. J Infect Dis 1947; 80:1-13.
5. Gimenez AP, Wu YZ, Paya M, Delclaux C, Touqui L, Goossens PL. High bactericidal efficiency of type iia phospholipase A2 against Bacillus anthracis and inhibition of its secretion by the lethal toxin. J Immunol 2004; 173:521-30.
6. Piris-Gimenez A, Paya M, Lambeau G, et al. In vivo protective role of human group IIA phospholipase A2 against experimental anthrax. J Immunol 2005; 175:6786-91.
7. Glomski IJ, Corre JP, Mock M, Goossens PL. Cutting edge: IFN-{gamma}-producing CD4 T lymphocytes mediate spore-induced immunity to capsulated Bacillus anthracis. J Immunol 2007; 178:2646-50.
8. Gold JA, Hoshino Y, Hoshino S, Jones MB, Nolan A, Weiden MD. Exogenous gamma and alpha/beta interferon rescues human macrophages from cell death induced by Bacillus anthracis. Infect Immun 2004; 72:1291-7.
9. Kang TJ, Fenton MJ, Weiner MA, et al. Murine macrophages kill the vegetative form of Bacillus anthracis. Infect Immun 2005; 73:7495-501.
10. Klezovich-Benard M, Corre JP, Jusforgues-Saklani H, et al. Mechanisms of NK cell-macrophage Bacillus anthracis crosstalk: a balance between stimulation by spores and differential disruption by toxins. PLoS Pathog 2012; 8:e1002481.
11. Dixon TC, Meselson M, Guillemin J, Hanna PC. Anthrax. N Engl J Med 1999; 341:815-26.
12. Moayeri M, Leppla SH. The roles of anthrax toxin in pathogenesis. Curr Opin Microbiol 2004; 7:19-24.
13. Moayeri M, Leppla SH. Cellular and systemic effects of anthrax lethal toxin and edema toxin. Mol Aspects Med 2009; 30:439-55.
14. Candela T, Fouet A. Bacillus anthracis CapD, belonging to the gamma-glutamyltranspeptidase family, is required for the covalent anchoring of capsule to peptidoglycan. Mol Microbiol 2005; 57:717-26.
15. Candela T, Mock M, Fouet A. CapE, a 47-amino-acid peptide, is necessary for Bacillus anthracis polyglutamate capsule synthesis. J Bacteriol 2005; 187:7765-72.
16. Piris-Gimenez A, Corre JP, Jouvion G, Candela T, Khun H, Goossens PL. Encapsulated Bacillus anthracis interacts closely with liver endothelium. J Infect Dis 2009; 200:1381-9.
17. Dumetz F, Jouvion G, Khun H, et al. Noninvasive imaging technologies reveal edema toxin as a key virulence factor in anthrax. Am J Pathol 2011; 178:2523-35.
18. Carr KA, Lybarger SR, Anderson EC, Janes BK, Hanna PC. The role of Bacillus anthracis germinant receptors in germination and virulence. Mol Microbiol 2010; 75:365-75.
19. Carr KA, Janes BK, Hanna PC. Role of the gerP operon in germination and outgrowth of Bacillus anthracis spores. PLoS One 2010; 5: e9128.
20. Heffron JD, Lambert EA, Sherry N, Popham DL. Contributions of four cortex lytic enzymes to germination of Bacillus anthracis spores. J Bacteriol 2010; 192:763-70.
21. Brittingham KC, Ruthel G, Panchal RG, et al. Dendritic cells endocytose Bacillus anthracis spores: implications for anthrax pathogenesis. J Immunol 2005; 174:5545-52.
22. Guidi-Rontani C, Weber-Levy M, Labruyere E, Mock M. Germination of Bacillus anthracis spores within alveolar macrophages. Mol Microbiol 1999; 31:9-17.
23. Hu H, Sa Q, Koehler TM, Aronson AI, Zhou D. Inactivation of Bacillus anthracis spores in murine primary macrophages. Cell Microbiol 2006; 8:1634-42.
24. Ruthel G, Ribot WJ, Bavari S, Hoover TA. Time-lapse confocal imaging of development of Bacillus anthracis in macrophages. J Infect Dis 2004; 189:1313-6.
25. Tournier JN, Quesnel-Hellmann A, Mathieu J, et al. Anthrax edema toxin cooperates with lethal toxin to impair cytokine secretion during infection of dendritic cells. J Immunol 2005; 174:4934-41.
26. Welkos S, Friedlander A, Weeks S, Little S, Mendelson I. In-vitro characterisation of the phagocytosis and fate of anthrax spores in macrophages and the effects of anti-PA antibody. J Med Microbiol 2002; 51:821-31.
27. Bischof TS, Hahn BL, Sohnle PG. Characteristics of spore germination in a mouse model of cutaneous anthrax. J Infect Dis 2007; 195:888-94.
28. Glomski IJ, Piris-Gimenez A, Huerre M, Mock M, Goossens PL. Primary involvement of pharynx and Peyer's patch in inhalational and intestinal anthrax. PLoS Pathog 2007; 3:e76.
29. Berthier M, Fauchere JL, Perrin J. Fulminant meningitis due to Bacillus anthracis in 11-year-old girl during Ramadan. Lancet 1996; 347:828.
30. Brossier F, Levy M, Mock M. Anthrax spores make an essential contribution to vaccine efficacy. Infect Immun 2002; 70:661-4.
31. Sylvestre P, Couture-Tosi E, Mock M. Polymorphism in the collagenlike region of the Bacillus anthracis BclA protein leads to variation in exosporium filament length. J Bacteriol 2003; 185:1555-63.
32. Arbuthnott JP, Arbuthnott ER, Arbuthnott AD, Pike WJ, Cockayne A. Investigation of microbial growth in vivo: evaluation of a novel in vivo chamber implant system. FEMS Microbiol Lett 1992; 79:75-9.
33. Pike WJ, Cockayne A, Webster CA, Slack RC, Shelton AP, Arbuthnott JP. Development and design of a novel in vivo chamber implant for the analysis of microbial virulence and assessment of antimicrobial therapy. Microb Pathog 1991; 10:443-50.
34. Cote CK, Van Rooijen N, Welkos SL. Roles of macrophages and neutrophils in the early host response to Bacillus anthracis spores in a mouse model of infection. Infect Immun 2006; 74:469-80.
35. Jones CA, Padula NL, Setlow P. Effect of mechanical abrasion on the viability, disruption and germination of spores of Bacillus subtilis. J Appl Microbiol 2005; 99:1484-94.
36. Couture-Tosi E, Ranck JL, Haustant G, Pehau-Arnaudet G, Sachse M. CEMOVIS on a pathogen: analysis of Bacillus anthracis spores. Biol Cell 2010; 102:609-19.
37. Hachisuka Y. Germination of B. anthracis spores in the peritoneal cavity of rats and establishment of anthrax. Jpn J Microbiol 1969; 13:199-207.
38. Pickering AK, Osorio M, Lee GM, Grippe VK, Bray M, Merkel TJ. Cytokine response to infection with Bacillus anthracis spores. Infect Immun 2004; 72:6382-9.
39. Ross JM. The pathogenesis of anthrax following the administration of spores by the respiratory route. J Pathol Bacteriol 1957; 73:485-94.
40. Gleiser CA. Pathology of anthrax infection in animal hosts. Fed Proc 1967; 26:1518-21.
41. Holt PG, Haining S, Nelson DJ, Sedgwick JD. Origin and steady-state turnover of class II MHC-bearing dendritic cells in the epithelium of the conducting airways. J Immunol 1994; 153:256-61.
42. Sylvestre P, Couture-Tosi E, Mock M. A collagen-like surface glycoprotein is a structural component of the Bacillus anthracis exosporium. Mol Microbiol 2002; 45:169-78.
43. Ghosh S, Scotland M, Setlow P. Levels of germination proteins in dormant and superdormant spores of Bacillus subtilis. J Bacteriol 2012; 194:2221-7.
44. Ghosh S, Setlow P. The preparation, germination properties and stability of superdormant spores of Bacillus cereus. J Appl Microbiol 2009; 108:582-90.
45. Kim C, Gajendran N, Mittrucker HW, et al. Human alpha-defensins neutralize anthrax lethal toxin and protect against its fatal consequences. Proc Natl Acad Sci USA 2005; 102:4830-5.
46. Mayer-Scholl A, Hurwitz R, Brinkmann V, et al. Human neutrophils kill Bacillus anthracis. PLoS Pathog 2005; 1:e23.
47. Wang W, Mulakala C, Ward SC, et al. Retrocyclins kill bacilli and germinating spores of Bacillus anthracis and inactivate anthrax lethal toxin. J Biol Chem 2006; 281:32755-64.
48. Glomski IJ, Fritz JH, Keppler SJ, et al. Murine splenocytes produce inflammatory cytokines in a MyD88-dependent response to Bacillus anthracis spores. Cell Microbiol 2007; 9:502-13.
49. Crawford MA, Aylott CV, Bourdeau RW, Bokoch GM. Bacillus anthracis toxins inhibit human neutrophil NADPH oxidase activity. J Immunol 2006; 176:7557-65.